ARKAY:OTC-Arkema S.A (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 122.88

Change

-1.64 (-1.32)%

Market Cap

USD 9.61B

Volume

1.10K

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. It operates in three segments: Adhesive Solutions, Advanced Materials, and Coating Solutions. Its products include acrylics, coating resins, electroactive polymers, fluorochemicals, fluoropolymers, functional polyolefins, hydrazine hydrate, hydrogen peroxide, molecular sieves, organic peroxide, oxygenated solvents, polyetherketoneketone, plastic additives, polymethyl methacrylate resins and sheets, rheology additives, solutions for glass coating, specialty adhesives, specialty polyamides, surfactants and additives, technical fluids, and thiochemicals. The company also offers UV, LED, EB curable resins, and specialty acrylates. It offers adhesive solutions used in building activities for businesses and individuals, including sealants, tile and flooring adhesives, and waterproofing systems, as well as in automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets; advanced materials used in the automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment; coating solutions for decorative paints, industrial coatings, adhesives, paper, superabsorbents, water treatment, oil and gas extraction, 3D printing, and electronics applications; and industrial intermediate chemicals for the construction, production of refrigeration and air conditioning, automotive, and water treatment applications. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-15 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SXYAY Sika AG

+0.48 (+1.69%)

USD40.20B 50.30 29.49
SKFOF Sika AG

N/A

USD40.00B 50.63 29.49
GVDBF Givaudan SA

N/A

USD38.56B 49.13 31.32
GVDNY Givaudan SA

+0.05 (+0.06%)

USD38.45B 48.10 31.32
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD33.11B 61.42 0.29
RDSMY Koninklijke DSM N.V

-0.06 (-0.12%)

USD30.57B 52.04 23.63
KDSKF Koninklijke DSM N.V

+0.48 (+0.27%)

USD30.35B 51.72 23.63
AKZOF Akzo Nobel N.V

-0.23 (-0.19%)

USD21.92B 29.94 17.08
AKZOY Akzo Nobel N.V

+0.70 (+1.81%)

USD21.52B 29.65 17.08
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.08B 44.21 36.74

ETFs Containing ARKAY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.99% 39% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.99% 40% F 36% F
Trailing 12 Months  
Capital Gain 64.94% 46% F 52% F
Dividend Return 3.19% 68% D+ 42% F
Total Return 68.12% 46% F 53% F
Trailing 5 Years  
Capital Gain 56.02% 54% F 58% F
Dividend Return 15.74% 88% B+ 56% F
Total Return 71.75% 56% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.92% 49% F 50% F
Dividend Return 2.54% 75% C 56% F
Total Return 9.46% 46% F 51% F
Risk Return Profile  
Volatility (Standard Deviation) 25.74% 66% D 68% D+
Risk Adjusted Return 36.74% 67% D+ 67% D+
Market Capitalization 9.61B 75% C 88% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.40 49% F 32% F
Price/Book Ratio 1.52 69% D+ 55% F
Price / Cash Flow Ratio 8.62 41% F 21% F
EV/EBITDA 8.19 60% D- 40% F
Management Effectiveness  
Return on Equity 6.35% 50% F 61% D-
Return on Invested Capital 4.80% 37% F 60% D-
Return on Assets 3.14% 55% F 75% C
Debt to Equity Ratio 49.24% 46% F 36% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.31 23% F 33% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector